We’re excited to share that swisscann has officially begun the first cultivation cycle of high-THC medical cannabis flowers at our GMP certified, state-of-the-art production facility in Zurich, Switzerland! This is a proud moment for us and a significant milestone in our company’s history.

At swisscann, we currently offer 5 distinct high-THC strains, ranging from 24% to 30% THC. These strains, derived from lab tissue culture, are cultivated and processed in our cutting-edge GMP certified facility. This ensures our products consistently meet the highest industry standards for quality and safety.

Holding the medical cannabis cultivation license, the narcotics handling license, and the GMP license issued by Swissmedic, swisscann is perfectly positioned to produce Active Pharmaceutical Ingredients (API).

Our premium medical cannabis flowers will soon be available in pharmacies across Switzerland and Germany, and shortly in the United Kingdom as well.

We invite you to join us in our mission to provide top-quality medical cannabis to improve patients’ quality of life. Stay tuned for more updates and exciting developments from swisscann!

Your swisscann-Team